Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L47 (Hepra peptide) plus peginterferon alfa-2a in chronic hepatitis B
CTR20210630Phase 2Completed
- Sponsor
- Shanghai Hepu Pharmaceutical
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Shanghai Hepu Pharmaceutical. Started Jun 2021; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20210630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210630.